Interleukin-17 as a new marker of severity of acute hepatic injury

Hepatology Research

Volumn 37, Issue 4, 2007, Pages 248-254

  Yasumi, Yuki ^a   Takikawa, Yasuhiro ^a   Endo, Ryujin ^a   Suzuki, Kazuyuki ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

Acute hepatic injury; Cytokine; Fulminant hepatic failure; IL 17; MELD score

Indexed keywords

BILIRUBIN; BIOLOGICAL MARKER; CREATININE; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 1BETA; PROTHROMBIN; TUMOR NECROSIS FACTOR ALPHA;

ACUTE HEPATITIS; ADULT; ANALYSIS OF VARIANCE; ARTICLE; BILIRUBIN BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIAGNOSTIC VALUE; DISEASE SEVERITY; FEMALE; HOSPITAL ADMISSION; HUMAN; INDEPENDENT VARIABLE; LIVER FAILURE; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTHROMBIN TIME; REFERENCE VALUE;

EID: 33947729690     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2007.00040.x     Document Type: Article

References (28)

1. Sato S, Suzuki K, Takikawa T et al. Clinical epidemiology of fulminant hepatitis in Japan before the substantial introduction of liver transplantation: An analysis of 1309 cases in a 15-year national survey. Hepatol Res 2004; 30: 155-61.
2. Fujiwara K. Japanese national survey of FH in 2000. In: Omata M, ed. The 2001 Annual Report of Research Group of Intractable Hepatitis, Tokyo. Tokyo: The Ministry of Health and Welfare of Japan, 2002; 87-96 (in Japanese).
3. Horney JT, Galambos JT. The liver during and after fulminant hepatitis. Gastroenterology 1977; 73: 639-45.
4. Kita Y, Umeshita K, Gotoh M et al. Quality of life in adult Japanese patients undergoing liver transplants overseas. Transpl Proc 1996; 28: 1934-6.
5. Humar A. Donor and recipient outcomes after adult living donor liver transplantation. Liver Transpl 2003; 9 (Suppl 2): S42-S44.
6. Popper H, Franklin M. Viral versus toxic hepatic necrosis. Arch Pathol 1948; 48: 338-76.
7. Omata M, Ehata T, Yokosuka O et al. Mutations in the precore region of hepatitis B virus DNA in patients with fulminant and severe hepatitis. N Engl J Med 1991; 324: 1699-704.
8. Muto Y, Nouri-Aria KT, Meager A et al. Enhanced tumour necrosis factor and interleukin-1 in fulminant hepatic failure. Lancet 1988; 2: 72-4.
9. Streetz K, Leifeld L, Grundmann D et al. Tumor necrosis factor alpha in the pathogenesis of human and murine fulminant hepatic failure. Gastroenterology 2000; 119: 446-60.
10. Ohta A, Sekimoto M, Sato M et al. Indispensable role for TNF-alpha and IFN-gamma at the effector phase of liver injury mediated by Th1 cells specific to hepatitis B virus surface antigen. J Immunol 2000; 165: 956-61.
11. Fujiwara K, Ogata I, Ohta Y et al. Intravascular coagulation in acute liver failure in rats and its treatment with antithrombin III. Gut 1988; 17: 1103-8.
12. Rolando N, Wade J, Davalos M et al. The systemic inflammatory response syndrome in acute liver failure. Hepatology 2000; 32: 734-9.
13. Koniaris LG, McKillop IH, Schwartz SI et al. TA. Liver regeneration. J Am Coll Surg 2003; 197: 634-59.
14. Fausto N. Liver regeneration and repair: Hepatocytes, progenitor cells, and stem cells. Hepatology 2004; 39: 1477-87.
15. Vignali DA. Multiplexed particle-based flow cytometric assays. J Immunol Methods 2000; 243: 243-55.
16. Kremers WK, van Ijperen M, Kim WR et al. MELD score as a predictor of pretransplant and posttransplant survival in OPTN/UNOS status 1 patients. Hepatology 2004; 39: 764-9.
17. Sato A, Takikawa Y, Sato S et al. Evaluation of effectiveness of glucocorticoid treatment using rat acute hepatic failure model. Acta Hepatol Jpn 1999; 40: 217-26 (in Japanese).
18. Sato S, Abe K, Onodera M et al. Serum interleukin-18 levels in patients with acute and fulminant hepatitis. Hepatology 2000; 32: 379A.
19. de Jager W, te Velthius H, Prakken BJ et al. Simultaneous detection of 15 human cytokines in a single sample of stimulated peripheral blood mononuclear cells. Clin Diagn Lab Immunol 2003; 10: 133-9.
20. Pickering WJ, Martin TB, Schorder MC et al. Comparison of a multiplex flow cytometric assay with enzyme-linked immunosorbent assay for quantification of antibodies to tetanus, diphtheria, and haemophilus influenzae Type b. Clin Diagn Lab Immunol 2002; 9: 872-6.
21. Kolls JK, Linden A. Interleukin-17 family members and inflammation. Immunity 2004; 21: 467-78.
22. Kawaguchi M, Adachi M, Oda N et al. IL-17 cytokine family. J Allergy Clin Immunol 2004; 114: 1265-73.
23. Gaffen SL. Biology of recently discovered cytokines: Interleukin-17-a unique inflammatory cytokine with roles in bone biology and arthritis. Arthritis Res Ther 2004; 6: 240-7.
24. Nakae SY, Komiyama A, Nambu K et al. Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity 2002; 17: 375-87.
25. Sakashita Y, Takikawa Y, Suzuki K. Relationship between plasma polymorphonuclear leukocyte elastase and coagulatory-fibrinolytis activities in acute hepatic injury. Acta Hepatol Jpn 1997; 38: 213-19.
26. Leifeld L, Cheng S, Ramakers J. Imbalanced intrahepatic expression of interleukin 12, interferon gamma, and interleukin 10 in fulminant hepatitis B. Hepatology 2002; 36: 1001-8.
27. Umemura M, Kawabe T, Shudo K et al. Involvement of IL-17 in Fas ligand-induced inflammation. Int Immunol 2004; 16: 1099-108.
28. Doherty DG, O'Farrelly C. Innate and adaptive lymphoid cells in human liver. Immnol Rev 2000; 174: 5-20.